79313560 - BIOSYNEX

Information

  • Trademark
  • 79313560
  • Serial Number
    79313560
  • Registration Number
    7159430
  • Filing Date
    May 11, 2021
    3 years ago
  • Registration Date
    September 12, 2023
    a year ago
  • Transaction Date
    January 02, 2024
    a year ago
  • Status Date
    September 12, 2023
    a year ago
  • Published for Opposition Date
    June 27, 2023
    a year ago
  • Location Date
    September 12, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SEVERSON, JUSTIN
  • Attorney Docket Number
    1300-1175
    Attorney Name
    JOSEPH SOFER
    Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
4000
Mark Identification
BIOSYNEX
Case File Statements
  • GS0051: Chemical and biological reagents and products for medical or veterinary purposes, namely, reagents for use in diagnostic tests, reagents for use in diagnostic tests for screening purposes, reagents for medical use, chemical reagents for medical purposes, diagnostic biomarker reagents for medical use; immunoassay reagents for medical use, reagent paper for medical purposes; reagents and preparations for pregnancy tests, chemical preparations for use in DNA medical analysis and Chemicals for use in RNA analysis for medical purposes; diagnostic products for medical purposes, namely, medical diagnostic test strips for the detection of coronavirus, viruses, bacteria or parasite for medical purposes, medical diagnostic test strips for measuring blood glucose levels, medical diagnostic test strips for measuring cholesterol levels, triglycerides, cardiac markers or any other biomedical marker; testing kits comprised of medical diagnostic agents, preparations and substances for medical purposes for use in disease detection, namely, coronavirus, HIV, respiratory viral infections, hepatitis B, hepatitis C, influenza, infectious mononucleosis, dengue, norovirus, rotavirus, adenovirus, urinary tract infections, colorectal cancer, C-reactive protein, cyclic citrullinated peptide, premature rupture of the fetal membranes, Chlamydia trachomatis, helicobacter pylori, legionnaire's disease, pneumonia, syphilis, tetanus, malaria, mycoses, herpes, rubella, whooping cough, Lyme disease; preparations and substances for medical purposes for use in drugs detection, namely, amphetamines, buprenorphine, cocaine, cotinine, methadone, fentanyl, methamphetamines, morphine, oxycodone, phencyclidine, cannabis, tramadol; pregnancy test kits and ovulation test kits for home use; diagnostic test kits comprised of medical diagnostic, for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; in vitro diagnostic preparations for medical use for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; self-testing diagnostic kits comprising in vitro diagnostic agents, preparations and substances for medical purposes for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic test kits for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents and assays for testing of body fluids for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; medical diagnostic reagents; chemical reagents for medical or veterinary purposes
  • GS0011: Chemical products for use in industry and science; chemical reagents, other than for medical or veterinary purposes ; diagnostic preparations other than for medical or veterinary purposes ; Chemically-treated nonmedical strips for chemical and biological analysis
  • GS0101: Diagnostic apparatus for medical purposes, namely, blood testing apparatus; genetic testing apparatus for medical purposes; diagnostic test readers for medical use; medical diagnostic apparatus for testing DNA and RNA samples; medical apparatus and instruments, namely, instruments for loop-mediated isothermal amplification for medical purposes; quantitative Polymerase Chain Reaction [PCR] instruments for medical use; real-time polymerase chain reaction (PCR) instruments for medical purposes; testing instruments for medical diagnostic purposes, namely, for the detection of coronavirus, viruses, bacteria or parasite for medical purposes; capillary tubes for samples; medical specimen cups; specimen cup holders; apparatus for taking body fluid samples, namely, medical devices for obtaining body fluid samples; gloves for medical purposes, sanitary masks for medical purposes, thermometers for medical use, chemically activated hot and cold gel packs for medical purposes; cooling patches for medical purposes; Ice bags for medical purposes, first-aid cooling patches, elastic bandages, Bandages for orthopaedic purposes
  • GS0421: Chemical analysis and research services; biological research; bacteriological research; chemical research; pharmaceutical research services; calibration of devices employed in such services
Case File Event Statements
  • 1/2/2024 - a year ago
    44 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/12/2023 - a year ago
    43 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/12/2023 - a year ago
    42 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/12/2023 - a year ago
    41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/12/2023 - a year ago
    40 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/12/2023 - a year ago
    39 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/27/2023 - a year ago
    38 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/27/2023 - a year ago
    37 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/25/2023 - a year ago
    36 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 6/7/2023 - a year ago
    35 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/7/2023 - a year ago
    34 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 6/7/2023 - a year ago
    33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/24/2023 - a year ago
    32 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/24/2023 - a year ago
    31 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/24/2023 - a year ago
    30 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/24/2023 - a year ago
    29 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/24/2023 - a year ago
    28 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/28/2023 - a year ago
    27 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 3/9/2023 - a year ago
    26 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 3/9/2023 - a year ago
    25 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 3/7/2023 - a year ago
    24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/6/2023 - a year ago
    23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/6/2023 - a year ago
    22 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 12/11/2022 - 2 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 11/23/2022 - 2 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/23/2022 - 2 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 9/9/2022 - 2 years ago
    18 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/9/2022 - 2 years ago
    17 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/9/2022 - 2 years ago
    16 - FINAL REFUSAL WRITTEN Type: CNFR
  • 8/23/2022 - 2 years ago
    15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/23/2022 - 2 years ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/23/2022 - 2 years ago
    13 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 8/9/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/8/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/8/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/27/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/7/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/7/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/20/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/19/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/19/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/29/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/23/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/17/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC